Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 02, 2016Lisa Giulino Roth, MD: How should we approach the adolescent/young adult Hodgkin lymphoma patient?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies23 minPlay
November 02, 2016George P. Canellos, MD, FASCO: Hodgkin disease: The past, the present, and the futureWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies28 minPlay
November 02, 2016Sonali M. Smith, MD: Should we use cell of origin and "double protein" expression in treating DLBCL?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies21 minPlay
November 02, 2016Kieron Dunleavy, MD: What's new in the approach to primary CNS lymphoma: Upfront and relapsedWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies18 minPlay
November 02, 2016David G. Maloney, MD, PhD: Debate: 60 y/o Follicular lymphoma patient relapsing less than 2 years after upfront R-CHOP - SCTWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies11 minPlay
November 02, 2016Jeremy S. Abramson, MD, MSc: Debate: 60 y/o Follicular lymphoma patient relapsing less than 2 years after upfront R-CHOP - Novel agentsWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies19 minPlay
November 02, 2016Kelly M. Trevino, PhD: Strategies to focus on quality of life in choosing lymphoma therapyWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies24 minPlay
November 02, 2016Adriana C. Rossi, MD: Combinations of myeloma: Should second and third line agents be used upfront?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies19 minPlay
November 02, 2016Jia Ruan, MD, PhD: What are the most promising new approaches and agents for T cell lymphoma?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies28 minPlay
October 25, 2016Miguel D. Regueiro, MD and Russell D. Cohen, MD, FACG, AGAF: Anti-TNF TherapyBest of the Day: Best of the Day: ACG 201613 minPlay